Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Nov 23:11:606414.
doi: 10.3389/fphar.2020.606414. eCollection 2020.

Editorial: Contemporary Perspective on 5-HT2C Receptor Function and Its Pharmacological Targeting

Philippe De Deurwaerdère  1 , Abdeslam Chagraoui  2   3 , Kathryn A Cunningham  4
Affiliations
Editorial

Editorial: Contemporary Perspective on 5-HT2C Receptor Function and Its Pharmacological Targeting

Philippe De Deurwaerdère et al. Front Pharmacol. .
No abstract available

Keywords: addiction; cell signaling; mRNA editing; monoamines; mood disorder; peptidomimetic; polymorphism; post-traumatic syndrome disorder.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Contemporary Perspective on 5-HT2C Receptor Function and Its Pharmacological Targeting

References

    1. Chagraoui A., Thibaut F., Skiba M., Thuillez C., Bourin M. (2016). 5-HT2C receptors in psychiatric disorders: a review. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 66, 120–135. 10.1016/j.pnpbp.2015.12.006 - DOI - PubMed
    1. Di Giovanni G., Bharatiya R., Puginier E., Ramos M., De Deurwaerdère S., Chagraoui A., et al. (2020). Lorcaserin alters serotonin and noradrenaline tissue content and their interaction with dopamine in the rat brain. Front. Pharmacol. 11, 962 10.3389/fphar.2020.00962 - DOI - PMC - PubMed
    1. Di Giovanni G., De Deurwaerdère P. (2016). New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders. Pharmacol. Ther. 157, 125–162. 10.1016/j.pharmthera.2015.11.009 - DOI - PubMed
    1. Higgins G. A., Fletcher P. J., Shanahan W. R. (2020). Lorcaserin: a review of its preclinical and clinical pharmacology and therapeutic potential. Pharmacol. Ther. 205, 107417 10.1016/j.pharmthera.2019.107417 - DOI - PubMed
    1. Howell L. L., Cunningham K. A. (2015). Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. Pharmacol. Rev. 67 (1), 176–197. 10.1124/pr.114.009514 - DOI - PMC - PubMed

Publication types

LinkOut - more resources